SPECTRA phase 2b study: impact of sotatercept on exercise tolerance and right ventricular function in pulmonary arterial hypertension

AB Waxman, DM Systrom, S Manimaran… - Circulation: Heart …, 2024 - Am Heart Assoc
BACKGROUND: This study aims to assess the impact of sotatercept on exercise tolerance,
exercise capacity, and right ventricular function in pulmonary arterial hypertension …
被引用次数：2 相关文章

SPECTRA Phase 2b Study: Impact of Sotatercept on Exercise Tolerance and Right Ventricular Function in Pulmonary Arterial Hypertension.

AB Waxman, DM Systrom, S Manimaran… - Circulation. Heart …, 2024 - europepmc.org
Background This study aims to assess the impact of sotatercept on exercise tolerance,
exercise capacity, and right ventricular function in pulmonary arterial hypertension. Methods …

SPECTRA Phase 2b Study: Impact of Sotatercept on Exercise Tolerance and Right Ventricular Function in Pulmonary Arterial Hypertension

AB Waxman, DM Systrom, S Manimaran… - 2024 - Am Heart Assoc
BACKGROUND: This study aims to assess the impact of sotatercept on exercise tolerance,
exercise capacity, and right ventricular function in pulmonary arterial hypertension …

SPECTRA Phase 2b Study: Impact of Sotatercept on Exercise Tolerance and Right Ventricular Function in Pulmonary Arterial Hypertension

AB Waxman, DM Systrom… - Circulation. Heart …, 2024 - pubmed.ncbi.nlm.nih.gov
Background This study aims to assess the impact of sotatercept on exercise tolerance,
exercise capacity, and right ventricular function in pulmonary arterial hypertension. Methods …